Kura Oncology Inc (NAS:KURA)
$ 8.86 -0.08 (-0.89%) Market Cap: 688.99 Mil Enterprise Value: 250.32 Mil PE Ratio: 0 PB Ratio: 1.63 GF Score: 29/100

Kura Oncology Inc To Discuss Preliminary Combo Data Call Transcript

Jan 30, 2024 / 01:00PM GMT
Release Date Price: $20.85 (+12.10%)
Operator

Good morning. My name is Krista, and I'll be your conference operator today. At this time, I would like to welcome everyone to the Kura Oncology virtual investor event. (Operator Instructions) Thank you. I would now like to turn the conference over to Troy Wilson, President and Chief Executive Officer of Oncology. Mr. Wilson, you may begin your conference.

Troy Wilson
Kura Oncology Inc - President, CEO, Board Member

Thank you, Krista, and good morning, everyone, and thank you for joining our call. I want to welcome you to our call to describe the preliminary clinical results from our KOMET-007 study. I'm here with my colleagues, Dr. Mollie Leoni and Dr. Stephen Dale. We're joined by Dr. Amir Zeidan and Dr. Amir Fathi as well, two investigators on the study. Each of them will take a turn in walking you through this set of slides.

If we turn now to slide number 3. We will be making on this call forward-looking statements. And I just want to draw your attention to our website, to the SEC website for more information about the risks and uncertainties in

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot